Financial insights of GEHC

MyFinsight

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total revenues	5,131	5,698	5,143	5,007
Cost of sales-Product	2,283	2,549	2,270	2,160
Cost of sales-Service	871	887	884	863
Gross profit	1,977	2,261	1,990	1,985
Selling, general, and administrative	1,117	1,111	1,045	1,029
Research and development	345	322	292	302
Total operating expenses	1,462	1,434	1,337	1,331
Operating income	515	827	653	654
Interest and other financial charges net	96	106	111	113
Non-operating benefit (income) costs	-51	-66	-75	-73
Net financing income and investment income (loss)	NaN	24	NaN	NaN
Equity method income (gain)	NaN	-1	NaN	NaN
Change in fair value of assumed obligations	NaN	-6	NaN	NaN
Gain on remeasurement of nmp equity method investment	NaN	0	NaN	NaN
Other items, net	NaN	15	NaN	NaN
Other (income) expense net	36	33	26	-1
Income before income taxes	505	820	643	613
Benefit (provision) for income taxes	94	218	179	113
Net income from continuing operations	NaN	602*	NaN	NaN
Income (loss) from discontinued operations, net of taxes	NaN	0*	NaN	NaN
Net income	411	602	464	500
Net (income) loss attributable to noncontrolling interests	22	14	18	14
Net income attributable to ge healthcare	389	588	446	486
Deemed preferred stock dividend of redeemable noncontrolling interest	NaN	0	NaN	NaN
Net income attributable to ge healthcare common stockholders	NaN	588	NaN	NaN

Basic EPS	0.85	1.295	0.98	1.06
Diluted EPS	0.85	1.284	0.98	1.06
Basic Average Shares	456,000,000	454,000,000	456,000,000	457,000,000
Diluted Average Shares	457,000,000	458,000,000	457,000,000	458,000,000

Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.